Neonatal Jaundice from ABO Incompatibility
What is Neonatal Jaundice from ABO Incompatibility?
Neonatal jaundice from ABO incompatibility happens when a mother and baby have different ABO blood types. The most common scenario is a mother with type O blood and a baby with type A or B blood. This difference causes the mother's immune system to create antibodies that can cross the placenta and attack the baby's red blood cells.
When the baby's red blood cells break down, they release a yellow pigment called bilirubin. The newborn's liver is still developing and may struggle to process this extra bilirubin quickly enough. This leads to jaundice, which appears as yellowing of the skin and eyes, usually within the first 24 to 48 hours after birth.
ABO incompatibility affects about 15 to 20 percent of pregnancies. Most cases are mild and resolve with simple treatment like phototherapy, which uses special blue light to break down bilirubin. Severe cases are rare but need prompt treatment to prevent complications.
Symptoms
- Yellow tint to the skin and the whites of the eyes
- Yellowing that starts on the face and spreads to the chest and stomach
- Pale or yellowish stools
- Dark, tea-colored urine
- Poor feeding or excessive sleepiness
- Lethargy or difficulty waking for feeds
- High-pitched crying or irritability
- Enlargement of the liver or spleen
Some babies show only mild yellowing of the skin that parents might miss in the first day or two. Jaundice from ABO incompatibility typically appears earlier than normal newborn jaundice, often within the first 24 hours of life.
Concerned about Neonatal Jaundice from ABO Incompatibility? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
ABO incompatibility occurs when maternal antibodies attack fetal red blood cells due to blood type differences. Mothers with type O blood naturally produce anti-A and anti-B antibodies. When a baby inherits type A or B blood from the father, these maternal antibodies can cross the placenta during pregnancy. Once in the baby's bloodstream, they attach to and destroy the baby's red blood cells, releasing bilirubin.
Unlike Rh incompatibility, ABO incompatibility can happen during a first pregnancy. The risk increases if the mother is type O and the father is type A, B, or AB. Babies with blood types A or B are more susceptible. Other factors that can worsen jaundice include prematurity, bruising during birth, feeding difficulties, and genetic conditions that affect red blood cell structure.
How it's diagnosed
Healthcare providers diagnose neonatal jaundice from ABO incompatibility through blood tests that check blood types and bilirubin levels. Testing the mother's and baby's ABO blood type and Rh factor helps identify incompatibility. A direct Coombs test, also called a direct antiglobulin test, detects antibodies attached to the baby's red blood cells. Bilirubin levels are measured to determine severity and guide treatment decisions.
Rite Aid offers ABO Blood Type and Rh Factor testing as an add-on to help identify blood type incompatibility risk before or during pregnancy. Early identification allows healthcare teams to monitor newborns more closely after birth. Additional tests like complete blood count and reticulocyte count may show evidence of ongoing red blood cell breakdown.
Treatment options
- Phototherapy using special blue light to break down bilirubin in the skin
- Frequent feeding every 2 to 3 hours to help the baby pass bilirubin through stool
- Supplemental fluids through IV if the baby is dehydrated or not feeding well
- Exchange transfusion for severe cases where the baby's blood is gradually replaced
- Close monitoring of bilirubin levels every few hours until they stabilize
- Treatment of any underlying conditions like infection or blood disorders
Need testing for Neonatal Jaundice from ABO Incompatibility? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Both involve blood type differences between mother and baby, but they affect different blood proteins. ABO incompatibility involves the A and B antigens on red blood cells and can occur during a first pregnancy. Rh incompatibility involves the Rh factor protein and typically becomes more severe with subsequent pregnancies. ABO incompatibility is usually milder and more common than Rh disease.
Yes, knowing the blood types of both parents helps identify potential ABO incompatibility risk. Testing the mother's and father's ABO blood type and Rh factor shows if their blood types could cause problems. If a mother has type O blood and the father has type A, B, or AB, healthcare providers monitor the baby more closely after birth for signs of jaundice.
Most cases resolve within 1 to 2 weeks with proper treatment. Jaundice typically appears in the first 24 to 48 hours after birth and peaks around day 3 to 5. With phototherapy and adequate feeding, bilirubin levels usually drop steadily. Babies are closely monitored until their bilirubin returns to safe levels and their liver can handle the processing on its own.
Most cases are mild and respond well to simple treatments like phototherapy. However, severe untreated jaundice can lead to a serious condition called kernicterus, where high bilirubin damages the brain. This is why healthcare providers monitor newborns carefully and treat rising bilirubin levels quickly. With proper medical care, the vast majority of babies recover completely without long-term effects.
Most babies with ABO incompatibility do not need blood transfusions. Phototherapy and frequent feeding are usually enough to bring bilirubin levels down safely. Exchange transfusions are reserved for severe cases where bilirubin rises dangerously high despite other treatments. This procedure is rare and only used when necessary to prevent brain damage.
Yes, breastfeeding is encouraged and helps reduce jaundice by promoting frequent bowel movements. Feeding your baby every 2 to 3 hours helps their body eliminate bilirubin through stool. Some babies may need supplemental feeding if they are too sleepy or not nursing effectively. Work with your healthcare team to create a feeding plan that supports both breastfeeding and treatment.
Healthcare providers use two methods to check bilirubin levels in newborns. A transcutaneous bilirubinometer is a handheld device that measures bilirubin through the skin without drawing blood. For more accurate readings, a blood test measures total serum bilirubin from a small blood sample. The method used depends on the baby's risk level and how high the bilirubin appears to be.
ABO incompatibility can occur in any pregnancy where the mother has type O blood and the baby has type A or B. Unlike Rh disease, it does not typically worsen with subsequent pregnancies. Each baby's risk depends on their inherited blood type from the father. Knowing your blood type helps your healthcare team prepare and monitor future newborns appropriately.
During phototherapy, the baby lies under special blue lights that change bilirubin into a form the body can eliminate more easily. The baby wears only a diaper and protective eye shields during treatment. Treatment is usually continuous except for feeding and diaper changes. Most babies need phototherapy for 1 to 2 days, depending on how quickly their bilirubin levels drop.
ABO incompatibility itself cannot be prevented because blood types are inherited traits. However, knowing blood types before or early in pregnancy allows healthcare providers to watch for signs of jaundice immediately after birth. Early detection and prompt treatment prevent complications. Unlike Rh disease, there is no preventive injection available for ABO incompatibility.